SpyGlass Pharma Appoints Chetan Pujara, Ph.D., as Chief Research & Development Officer
Chetan Pujara, Ph.D Chief Research & Development Officer, SpyGlass Pharma Dr. Pujara brings extensive industry experience to ...
Managed Healthcare Executive3d
Is Journavx a Step Forward In Pain Management or a Repeat of Past Mistakes?
Doerring, M.D., former FDA medical officer in the division of psychiatry and the founder and CEO of TaperClinic, he shares ...
Syncromune Appoints Zhihong Li, Ph.D., as Chief Regulatory Affairs Officer to Lead Global Regulatory Strategy for Novel Oncology Immunotherapies
FORT LAUDERDALE, Fla. and WEST DES MOINES, Iowa, March 25, 2025 (GLOBE NEWSWIRE) -- Syncromune® Inc., a clinical-stage biopharmaceutical company developing SYNC-T, an in situ personalized ...
The Manila Times12h
AEON Biopharma Announces CEO Transition
- Jost Fischer, Chairman of AEON, will assume the role of interim CEO - ...
The Manila Times1d
Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer
WEST CHESTER, Pa., March 26, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. ("Verrica” or the "Company”) (Nasdaq: VRCA ...
Millions of women get painful UTIs that keep coming back. A new kind of antibiotic may help break the cycle
The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, ...
MyChesCo on MSN2h
Verrica Pharmaceuticals Appoints Dr. Noah Rosenberg as Chief Medical Officer
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced the appointment of Dr. Noah L. Rosenberg as ...
Fierce Biotech6d
Chutes & Ladders—Former FDA deputy joins AI biotech's board
About three months after leaving her post as the FDA’s principal deputy commissioner, Namandjé Bumpus, Ph.D., has found a new ...
Dallas 'Bachelor' star dog attack captured on body camera footage
The Bachelor star, who lives in University Park with his wife Catherine, said he was recently attacked by his own dog.
FDA approves a new kind of oral antibiotic to treat urinary tract infections
Blujepa is the first new type of oral antibiotic to treat UTIs to gain approval in more than 20 years. Its development was ...
FDA Reinstates Fired Probationary Workers After Judge's Order
The FDA is reinstating fired probationary workers after a federal judge ruled their terminations were unlawful and must be ...
BioSpace1d
GSK Wins FDA Nod for First Oral UTI Antibiotic in Almost 30 Years
Blujepa, which treats UTIs in female patients aged 12 and up with common and uncomplicated infections, will hit the market in ...